Schmeing Lab – December, 2024
The focus of the Schmeing lab is on understanding how large, natural biosynthetic enzymes make their interesting and valuable products. Two of our favorite types of biosynthetic enzymes are nonribosomal peptide synthetases, NRPSs, which synthesize compounds like the antibiotic daptomycin, the anti-tumour actinomycin and the immunosuppressant cyclosporin, and cyanophycin synthetase, which makes an extremely useful green polymer. We combine cryo-EM, crystallography, chemical biology, biophysical and biochemical techniques to visualize and understand these awesome enzymes.
Stay tuned for more exciting features, and don’t miss the chance to get your lab featured!
Please contact Lars Sahl to get involved!
Peptide Purification
In this sponsored content by Gyros Protein Technologies, learn how to remove impurities faster with less solvent consumption using catch-and-release technology.
Peptide-related impurities can significantly influence the outcome of drug research and development, for example, false-positive results, and must be removed to ensure high assay reliability.
Ultimately, such impurities must be removed entirely from active pharmaceutical ingredients to provide the highest quality clinical-grade material. This article tells you how.
What Current Members Say
“Being an APS member provides a great platform for networking and establishing new collaborations with scientists from around the world with similar scientific interests.”
Eileen Kennedy
Georgia Athletic Association Professor of Pharmacy
University of Georgia
“I have been a member of APS since I was a graduate student because of the benefits and opportunities it provided scientists at that stage of my career. Through the years, I have continued to be a member so I can engage with the top researchers working in peptide science from around the globe.”
Marcos Pires
Associate Professor of Chemistry
University of Virginia
“Being a member of the American Peptide Society and attending the Peptide Symposium, one of the key asset of the society, I have gain new perspectives on emerging peptide technologies, and gain insights about current challenges from prominent peptide leaders. It is a great society for the education and professional development for our peptide scientist.”
Ved Srivastava
Ph.D., Vice President of Peptide Chemistry
Intarcia Therapeutics